Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF CHINA IMMUNOASSAY REAGENTS AND DEVICE MARKET
1.4 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 MARKET END USER COVERAGE GRID
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 PREMIUM INSIGHTS
5.1 PESTAL ANALYSIS
5.2 PORTER'S FIVE FORCES ANALYSIS
5.3 TECHNOLOGICAL ADVANCEMENTS IN THE TECHNOLOGICAL ADVANCEMENTS IN THE GLOBAL NATURAL TERPENE MARKET
5.4 MICRO AND MACRO ECONOMIC FACTORS
5.5 PENETRATION AND GROWTH PROSPECT MAPPING
5.6 KEY PRICING STRATEGIES
5.7 INTELLECTUAL PROPERTY (IP) PORTFOLIO ANALYSIS
5.7.1 PATENT QUALITY AND STRENGTH
5.7.2 AND COLLABORATIONS
5.8 COST STRUCTURE BREAKDOWN
5.8.1 IMMUNOASSAY REAGENTS
5.8.2 IMMUNOASSAY DEVICES (ANALYZERS):
5.9 REGULATORY COMPLIANCE
5.9.1 REGULATORY AUTHORITIES
5.9.2 REGULATORY CLASSIFICATIONS
5.9.2.1 CLASS I (LOW RISK)
5.9.2.2 CLASS II (MODERATE RISK)
5.9.2.3 CLASS III (HIGH RISK)
5.9.3 REGULATORY SUBMISSIONS
5.9.4 INTERNATIONAL HARMONIZATION
5.9.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
5.9.6 REGULATORY CHALLENGES AND STRATEGIES
5.1 OPPORTUNITY MAP ANALYSIS
5.11 VALUE CHAIN ANALYSIS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES
6.1.2 RISING HEALTHCARE INVESTMENTS IN DIAGNOSTIC TECHNOLOGIES
6.1.3 GROWING DEMAND FOR PERSONALIZED MEDICINE AND TREATMENTS
6.1.4 TECHNOLOGICAL ADVANCEMENTS IN IMMUNOASSAY REAGENTS AND DEVICES
6.2 RESTRAINTS
6.2.1 FRAGMENTED MARKET WITH INTENSE LOW-COST COMPETITION CAUSING PRICING PRESSURE
6.2.2 STRINGENT REGULATORY APPROVAL PROCESSES FOR NEW PRODUCTS
6.3 OPPORTUNITIES
6.3.1 GROWTH IN RESEARCH AND DEVELOPMENT OF IMMUNOASSAYS
6.3.2 EXPANSION OF POINT-OF-CARE IMMUNOASSAY TESTING
6.3.3 INDUSTRY COLLABORATIONS ADVANCING IMMUNOASSAY CAPABILITIES
6.4 CHALLENGES
6.4.1 HIGH COST OF ADVANCED IMMUNOASSAY SYSTEMS AND IMPLEMENTATION
6.4.2 SHORTAGE OF SKILLED WORKFORCE AND TECHNICAL EXPERTISE
7 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 IMMUNOASSAY REAGENTS & KITS
7.2.1 CHEMILUMINESCENCE IMMUNOASSAYS KITS AND REAGENTS
7.2.2 ELISA KITS AND REAGENTS
7.2.3 RAPID TEST KITS AND REAGENTS
7.2.4 IMMUNOHISTOCHEMISTRY ASSAYS KITS AND REAGENTS
7.2.5 BEAD-BASED IMMUNOASSAYS KITS AND REAGENTS
7.2.6 WESTERN BLOT KITS AND REAGENTS
7.2.7 ELISPOT KITS AND REAGENTS
7.2.8 RADIOIMMUNOASSAY KITS AND REAGENTS
7.2.9 MICROARRAY IMMUNOASSAYS KITS AND REAGENTS
7.2.10 MULTIPLEX MICROARRAY ASSAYS KITS AND REAGENTS
7.2.11 OTHER IMMUNOASSAY KITS AND REAGENTS
7.3 IMMUNOASSAY DEVICES
7.3.1 ANALYZERS
7.3.1.1 AUTOMATIC ANALYZERS
7.3.1.1.1 CLOSED-ENDED SYSTEMS
7.3.1.1.1.1 MODULAR
7.3.1.1.1.2 FLOOR-STANDING
7.3.1.1.1.3 BENCH-TOP
7.3.1.1.1.4 OTHERS
7.3.1.1.2 OPEN-ENDED SYSTEMS
7.3.1.1.2.1 BENCH-TOP
7.3.1.1.2.2 FLOOR-STANDING
7.3.1.1.2.3 MODULAR
7.3.1.1.2.4 OTHERS
7.3.1.2 SEMI-AUTOMATIC ANALYZERS
7.3.1.2.1 BENCH-TOP
7.3.1.2.2 FLOOR-STANDING
7.3.1.2.3 MODULAR
7.3.1.2.4 OTHERS
7.3.1.1 RENTAL PURCHASE
7.3.1.2 OUTRIGHT PURCHASE
7.3.1.1 BENCH-TOP
7.3.1.2 FLOOR-STANDING
7.3.1.3 MODULAR
7.3.1.4 OTHERS
7.3.2 ACCESSORIES AND CONSUMABLES
7.3.2.1 THERMAL PRINTER
7.3.2.2 BARCODE SCANNER
7.3.2.3 OTHERS
7.3.3 POCT DEVICES
7.3.3.1 BENCH-TOP
7.3.3.2 HANDHELD
8 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM
8.1 OVERVIEW
8.2 CHEMILUMINESCENCE IMMUNOASSAYS (CLIA)
8.3 ENZYME IMMUNOASSAY (EIA/ELISA)
8.3.1 ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA)
8.3.1.1 THIRD-GENERATION ELISA
8.3.1.2 FOURTH-GENERATION ELISA
8.3.1.3 SECOND-GENERATION ELISA
8.3.1.4 FIRST-GENERATION ELISA
8.3.2 ENZYME LINKED FLUORESCENT IMMUNOASSAY (ELFA)
8.4 FLUORESCENCE IMMUNOASSAYS (FIA)
8.5 CHROMATOGRAPHIC IMMUNOASSAYS
8.6 IMMUNOHISTOCHEMISTRY
8.7 RADIOIMMUNOASSAYS (RIA)
8.8 TURBIDIMETRIC IMMUNOASSAYS
8.9 MICROARRAY IMMUNOASSAYS
8.1 COUNTING IMMUNOASSAYS
8.11 OTHERS
9 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE
9.1 OVERVIEW
9.2 LABORATORY BASED
9.3 POINT OF CARE
10 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE
10.1 OVERVIEW
10.2 BLOOD
10.3 URINE
10.4 SALIVA
10.5 OTHERS
11 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 INFECTIOUS DISEASES
11.2.1 IMMUNOASSAY REAGENTS & KITS
11.2.2 IMMUNOASSAY DEVICES
11.3 CANCER BIOMARKERS
11.3.1 CARCINO EMBRYONIC ANTIGEN (CEA)
11.3.1.1 IMMUNOASSAY REAGENTS & KITS
11.3.1.2 IMMUNOASSAY DEVICES
11.3.2 ALPHA-FETOPROTEIN (AFP)
11.3.2.1 IMMUNOASSAY REAGENTS & KITS
11.3.2.2 IMMUNOASSAY DEVICES
11.3.3 CARBOHYDRATE ANTIGEN 19-9 (CA 19-9)
11.3.3.1 IMMUNOASSAY REAGENTS & KITS
11.3.3.2 IMMUNOASSAY DEVICES
11.3.4 CARBOHYDRATE ANTIGEN 125 (CA 125)
11.3.4.1 IMMUNOASSAY REAGENTS & KITS
11.3.4.2 IMMUNOASSAY DEVICES
11.3.5 OTHERS
11.3.5.1 IMMUNOASSAY REAGENTS & KITS
11.3.5.2 IMMUNOASSAY DEVICES
11.4 ENDOCRINOLOGY
11.4.1 IMMUNOASSAY REAGENTS & KITS
11.4.2 IMMUNOASSAY DEVICES
11.5 BONE AND MINERAL DISORDERS
11.5.1 IMMUNOASSAY REAGENTS & KITS
11.5.2 IMMUNOASSAY DEVICES
11.6 CARDIOLOGY
11.6.1 IMMUNOASSAY REAGENTS & KITS
11.6.2 IMMUNOASSAY DEVICES
11.7 HEMATOLOGY AND BLOOD SCREENING
11.7.1 IMMUNOASSAY REAGENTS & KITS
11.7.2 IMMUNOASSAY DEVICES
11.8 AUTOIMMUNE DISORDERS
11.8.1 IMMUNOASSAY REAGENTS & KITS
11.8.2 IMMUNOASSAY DEVICES
11.9 TOXICOLOGY
11.9.1 IMMUNOASSAY REAGENTS & KITS
11.9.2 IMMUNOASSAY DEVICES
11.1 NEONATAL SCREENING
11.10.1 IMMUNOASSAY REAGENTS & KITS
11.10.2 IMMUNOASSAY DEVICES
11.11 ALLERGY DIAGNOSTICS
11.11.1 IMMUNOASSAY REAGENTS & KITS
11.11.2 IMMUNOASSAY DEVICES
11.12 GASTROLOGY
11.12.1 IMMUNOASSAY REAGENTS & KITS
11.12.2 IMMUNOASSAY DEVICES
11.13 OTHERS
11.13.1 IMMUNOASSAY REAGENTS & KITS
11.13.2 IMMUNOASSAY DEVICES
12 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS
12.2.1 PUBLIC
12.2.2 PRIVATE
12.2.3 TIER 3
12.2.4 TIER 2
12.2.5 TIER 1
12.3 CLINICAL LABORATORIES
12.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
12.5 BLOOD BANKS
12.6 RESEARCH AND ACADEMIC LABORATORIES
12.7 AMBULATORY CARE CENTERS
12.8 NURSING HOMES
12.9 HOME HEALTHCARE AGENCIES
12.1 OTHERS
13 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: CHINA
14 SWOT ANALYSIS
15 COMPANY PROFILES
15.1 F. HOFFMANN-LA ROCHE LTD
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 PRODUCT PORTFOLIO
15.1.4 RECENT DEVELOPMENT/NEWS
15.2 SIEMENS
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 PRODUCT PORTFOLIO
15.2.4 RECENT DEVELOPMENT
15.3 ABBOTT
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 PRODUCT PORTFOLIO
15.3.4 RECENT DEVELOPMENT/NEWS
15.4 THERMO FISHER SCIENTIFIC INC.
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 PRODUCT PORTFOLIO
15.4.4 RECENT DEVELOPMENT
15.5 QUIDELORTHO CORPORATION
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 PRODUCT PORTFOLIO
15.5.4 RECENT DEVELOPMENT/NEWS
15.6 AGILENT TECHNOLOGIES, INC
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENT
15.7 BD
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT DEVELOPMENT/NEWS
15.8 BIO RAD LABORATORIES INC
15.8.1 COMPANY SNAPSHOT
15.8.2 REVENUE ANALYSIS
15.8.3 PRODUCT PORTFOLIO
15.8.4 RECENT DEVELOPMENT
15.9 BIO-TECHNE
15.9.1 COMPANY SNAPSHOT
15.9.2 REVENUE ANALYSIS
15.9.3 PRODUCT PORTFOLIO
15.9.4 RECENT DEVELOPMENT
15.1 BIOMERIEUX
15.10.1 COMPANY SNAPSHOT
15.10.2 REVENUE ANALYSIS
15.10.3 PRODUCT PORTFOLIO
15.10.4 RECENT DEVELOPMENT
15.11 DANAHER CORPORATION
15.11.1 COMPANY SNAPSHOT
15.11.2 REVENUE ANALYSIS
15.11.3 PRODUCT PORTFOLIO
15.11.4 RECENT DEVELOPMENT
15.12 DIASORIN
15.12.1 COMPANY SNAPSHOT
15.12.2 REVENUE ANALYSIS
15.12.3 PRODUCT PORTFOLIO
15.12.4 RECENT DEVELOPMENT/NEWS
15.13 HIPRO BIOTECHNOLOGY CO.LTD.
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENT
15.14 QIAGEN
15.14.1 COMPANY SNAPSHOT
15.14.2 REVENUE ANALYSIS
15.14.3 PRODUCT PORTFOLIO
15.14.4 RECENT DEVELOPMENT
15.15 REVVITY
15.15.1 COMPANY SNAPSHOT
15.15.2 REVENUE ANALYSIS
15.15.3 PRODUCT PORTFOLIO
15.15.4 RECENT DEVELOPMENT
15.16 SD BIOSENSOR, INC.
15.16.1 COMPANY SNAPSHOT
15.16.2 REVENUE ANALYSIS
15.16.3 PRODUCT PORTFOLIO
15.16.4 RECENT DEVELOPMENT
15.17 SYSMEX CORPORATION
15.17.1 COMPANY SNAPSHOT
15.17.2 REVENUE ANALYSIS
15.17.3 PRODUCT PORTFOLIO
15.17.4 RECENT DEVELOPMENT
15.18 TOSOH BIOSCIENCE, INC
15.18.1 COMPANY SNAPSHOT
15.18.2 REVENUE ANALYSIS
15.18.3 PRODUCT PORTFOLIO
15.18.4 RECENT DEVELOPMENT
16 QUESTIONNAIRE
17 RELATED REPORTS
List of Table
TABLE 1 PENETRATION AND GROWTH PROSPECT MAPPING ANALYSIS
TABLE 2 IMMUNOASSAY REAGENTS COST STRUCTURE BREAKDOWN
TABLE 3 IMMUNOASSAY DEVICES (ANALYZERS)
TABLE 4 OPPORTUNITY MAP ANALYSIS (TECHNOLOGY)
TABLE 5 OPPORTUNITY MAP ANALYSIS (APPLICATION AREA)
TABLE 6 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 7 CHINA IMMUNOASSAY REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 8 CHINA IMMUNOASSAY REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 9 CHINA IMMUNOASSAY REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 10 CHINA IMMUNOASSAY DEVICES IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 11 CHINA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 12 CHINA AUTOMATIC ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 13 CHINA CLOSED-ENDED SYSTEMS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 14 CHINA CLOSED-ENDED SYSTEMS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 15 CHINA CLOSED-ENDED SYSTEMS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 16 CHINA OPEN-ENDED SYSTEMS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 17 CHINA OPEN-ENDED SYSTEMS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 18 CHINA OPEN-ENDED SYSTEMS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 19 CHINA SEMI-AUTOMATIC ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 20 CHINA SEMI-AUTOMATIC ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 21 CHINA SEMI-AUTOMATIC ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 22 CHINA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PURCHASE MODE, 2018-2032 (USD THOUSAND)
TABLE 23 CHINA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 24 CHINA ACCESSORIES AND CONSUMABLES IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 25 CHINA POCT DEVICES IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 26 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)
TABLE 27 CHINA ENZYME IMMUNOASSAY IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 28 CHINA ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA) IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 29 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY ISOTOPE, 2018-2032 (USD THOUSAND)
TABLE 30 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 31 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 32 CHINA INFECTIOUS DISEASES IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 33 CHINA CANCER BIOMARKERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 34 CHINA CARCINO EMBRYONIC ANTIGEN (CEA) IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 35 CHINA ALPHA-FETOPROTEIN (AFP) IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 36 CHINA CARBOHYDRATE ANTIGEN 19-9 (CA 19-9) IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 37 CHINA CARBOHYDRATE ANTIGEN 125 (CA 125) IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 38 CHINA OTHERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 39 CHINA ENDOCRINOLOGY IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 40 CHINA BONE AND MINERAL DISORDERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 41 CHINA CARDIOLOGY IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 42 CHINA HEMATOLOGY AND BLOOD SCREENING IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 43 CHINA AUTOIMMUNE DISORDERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 44 CHINA TOXICOLOGY IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 45 CHINA NEONATAL SCREENING IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 46 CHINA ALLERGY DIAGNOSTICS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 47 CHINA GASTROLOGY IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 48 CHINA OTHERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 49 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 50 CHINA HOSPITALS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 51 CHINA HOSPITALS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
List of Figure
FIGURE 1 CHINA IMMUNOASSAY REAGENTS AND DEVICE MARKET: SEGMENTATION
FIGURE 2 CHINA IMMUNOASSAY REAGENTS AND DEVICE MARKET: DATA TRIANGULATION
FIGURE 3 CHINA IMMUNOASSAY REAGENTS AND DEVICE MARKET: DROC ANALYSIS
FIGURE 4 CHINA IMMUNOASSAY REAGENTS AND DEVICE MARKET: CHINA VS REGIONAL MARKET ANALYSIS
FIGURE 5 CHINA IMMUNOASSAY REAGENTS AND DEVICE MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 CHINA IMMUNOASSAY REAGENTS AND DEVICE MARKET: MULTIVARIATE MODELLING
FIGURE 7 CHINA IMMUNOASSAY REAGENTS AND DEVICE MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 CHINA IMMUNOASSAY REAGENTS AND DEVICE MARKET: DBMR MARKET POSITION GRID
FIGURE 9 CHINA IMMUNOASSAY REAGENTS AND DEVICE MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 CHINA IMMUNOASSAY REAGENTS AND DEVICE MARKET: MARKET END USER COVERAGE GRID
FIGURE 11 CHINA IMMUNOASSAY REAGENTS AND DEVICE MARKET: SEGMENTATION
FIGURE 12 TWO SEGMENTS COMPRISE THE CHINA IMMUNOASSAY REAGENTS AND DEVICE MARKET, BY PRODUCT TYPE (2024)
FIGURE 13 CHINA IMMUNOASSAY REAGENTS AND DEVICE MARKET: EXECUTIVE SUMMARY
FIGURE 14 STRATEGIC DECISIONS
FIGURE 15 LINE CHART, BY ISOTOPE (2024)
FIGURE 16 RISING HEALTHCARE INVESTMENTS IN DIAGNOSTIC TECHNOLOGIES IS EXPECTED TO DRIVE THE CHINA IMMUNOASSAY REAGENTS AND DEVICE MARKET IN THE FORECAST PERIOD (2025-2032)
FIGURE 17 IMMUNOASSAY REAGENTS & KITS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE CHINA IMMUNOASSAY REAGENTS AND DEVICE MARKET IN 2025 & 2032
FIGURE 18 DROC ANALYSIS
FIGURE 19 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY PRODUCT TYPE, 2024
FIGURE 20 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY PRODUCT TYPE, 2025 TO 2032 (USD THOUSAND)
FIGURE 21 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY PRODUCT TYPE, CAGR (2025- 2032)
FIGURE 22 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 23 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY PLATFORM, 2024
FIGURE 24 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY PLATFORM, 2025 TO 2032 (USD THOUSAND)
FIGURE 25 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY PLATFORM, CAGR (2025- 2032)
FIGURE 26 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY PLATFORM, LIFELINE CURVE
FIGURE 27 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY TYPE, 2024
FIGURE 28 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY TYPE, 2025 TO 2032 (USD THOUSAND)
FIGURE 29 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY TYPE, CAGR (2025- 2032)
FIGURE 30 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY TYPE, LIFELINE CURVE
FIGURE 31 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY SPECIMEN TYPE, 2024
FIGURE 32 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY SPECIMEN TYPE, 2025 TO 2032 (USD THOUSAND)
FIGURE 33 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY SPECIMEN TYPE, CAGR (2025- 2032)
FIGURE 34 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY SPECIMEN TYPE, LIFELINE CURVE
FIGURE 35 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY APPLICATION, 2024
FIGURE 36 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY APPLICATION, 2025 TO 2032 (USD THOUSAND)
FIGURE 37 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY APPLICATION, CAGR (2025- 2032)
FIGURE 38 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 39 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY END USER, 2024
FIGURE 40 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY END USER, 2025 TO 2032 (USD THOUSAND)
FIGURE 41 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY END USER, CAGR (2025- 2032)
FIGURE 42 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY END USER, LIFELINE CURVE
FIGURE 43 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET: COMPANY SHARE 2024 (%)
